Table 3.
ID | LDL* (mmol/ L) Pre- Statin |
LDL* (mmol/L) Post- Statin |
% Decrease LDL |
CoQ10 Reduced Pre- Statin |
CoQ10 Reduced Post- Statin |
% Decrease CoQ10 Reduced |
CoQ10 Reduced /LDL Pre- Statin |
CoQ10 Reduced /LDL Post- Statin |
% Decrease CoQ10 Reduced /LDL |
CoQ10 Oxidized Pre- Statin |
CoQ10 Oxidized Post- Statin |
% Decrease CoQ10 Oxidized |
CoQ10 Oxidized /LDL Pre- Statin |
CoQ10 Oxidized /LDL Post- Statin |
% Decrease CoQ10 Oxidized /LDL |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Subgroup 1. No History of Myalgia−Placebo+Statin | |||||||||||||||
1 | 4.09 | 2.53 | 38.0 | 1.04 | 0.58 | 44.5 | 0.25 | 0.23 | 10.6 | 0.098 | 0.041 | 58.2 | 0.024 | 0.016 | 32.5 |
2 | 4.76 | 3.36 | 29.3 | 1.13 | 0.92 | 18.5 | 0.24 | 0.27 | −15.4 | 0.113 | 0.032 | 71.7 | 0.024 | 0.010 | 59.9 |
3 | 4.19 | 1.99 | 52.5 | 0.83 | 0.49 | 41.0 | 0.20 | 0.24 | −24.0 | 0.202 | 0.034 | 83.2 | 0.048 | 0.017 | 64.6 |
4 | 4.37 | 2.95 | 32.5 | 0.96 | 0.83 | 13.5 | 0.22 | 0.28 | −28.2 | 0.065 | 0.046 | 29.2 | 0.015 | 0.016 | −4.9 |
5 | 4.09 | 2.59 | 36.7 | 0.76 | 0.54 | 28.7 | 0.19 | 0.21 | −12.6 | 0.062 | 0.030 | 51.6 | 0.015 | 0.012 | 23.5 |
Subgroup 2. History of Myalgia−Placebo+Statin | |||||||||||||||
6 | 5.79 | 3.75 | 35.3 | 1.58 | 0.82 | 47.9 | 0.27 | 0.22 | 19.5 | 0.152 | 0.068 | 55.3 | 0.026 | 0.018 | 30.9 |
7 | 5.90 | 2.84 | 51.8 | 0.93 | 0.44 | 53.0 | 0.16 | 0.15 | 2.5 | 0.063 | 0.036 | 42.9 | 0.011 | 0.013 | −18.4 |
8 | 5.20 | 3.96 | 23.9 | 1.47 | 1.05 | 28.5 | 0.28 | 0.27 | 6.1 | 0.052 | 0.176 | −238 | 0.010 | 0.044 | −345 |
9 | 3.18 | 2.59 | 18.7 | 1.28 | 1.14 | 11.0 | 0.40 | 0.44 | −9.5 | 0.078 | 0.064 | 17.9 | 0.025 | 0.025 | −0.9 |
Subgroup 3. No History of Myalgia−Ubiquinol+Statin | |||||||||||||||
10 | 6.03 | 4.53 | 24.9 | 0.90 | 3.97 | −340 | 0.15 | 0.88 | −486 | 0.076 | 0.152 | −100 | 0.013 | 0.034 | −166 |
11 | 3.52 | 2.59 | 26.5 | 0.76 | 4.32 | −467 | 0.22 | 1.67 | −671 | 0.123 | 0.213 | −73.2 | 0.035 | 0.082 | −136 |
12 | 4.32 | 3.52 | 18.6 | 0.99 | 4.91 | −395 | 0.23 | 1.39 | −508 | 0.045 | 0.171 | −280 | 0.010 | 0.049 | −367 |
13 | 2.20 | 1.47 | 32.9 | 0.78 | 6.04 | −674 | 0.35 | 4.10 | −1054 | 0.074 | 0.296 | −300 | 0.034 | 0.201 | −497 |
14 | 4.84 | 2.59 | 46.5 | 1.12 | 7.01 | −523 | 0.23 | 2.71 | −1065 | 0.113 | 0.143 | −26.5 | 0.023 | 0.055 | −137 |
15 | 4.19 | 2.59 | 38.3 | 0.75 | 7.05 | −839 | 0.18 | 2.72 | −1422 | 0.035 | 0.163 | −366 | 0.008 | 0.063 | −655 |
Subgroup 4. History of Myalgia−Ubiquinol+Statin | |||||||||||||||
16 | 4.19 | 2.72 | 35.2 | 1.46 | 4.90 | −234 | 0.35 | 1.80 | −416 | 0.124 | 0.180 | −45.2 | 0.030 | 0.066 | −124 |
17 | 4.63 | 3.08 | 33.5 | 0.57 | 5.49 | −863 | 0.12 | 1.78 | −1348 | 0.110 | 0.136 | −23.6 | 0.024 | 0.044 | −86 |
18 | 6.03 | 3.57 | 40.8 | 1.09 | 6.51 | −497 | 0.18 | 1.83 | −908 | 0.070 | 0.086 | −22.9 | 0.012 | 0.024 | −107 |
19 | 3.96 | 2.28 | 42.5 | 0.72 | 4.45 | −518 | 0.18 | 1.96 | −974 | 0.040 | 0.202 | −405 | 0.010 | 0.089 | −778 |
20 | 3.21 | 2.40 | 25.0 | 3.78 | 2.16 | 42.9 | 1.18 | 0.90 | 23.9 | 0.179 | 0.052 | 70.9 | 0.056 | 0.022 | 61.3 |
21 | 2.66 | 2.87 | −7.8 | 0.58 | 0.68 | −16.3 | 0.22 | 0.24 | −8.0 | 0.032 | 0.032 | 0 | 0.012 | 0.011 | 7.2 |
To convert LDL (low density lipoprotein) from SI units (mmol/L) to mg/dL multiply by 38.67.